Today, we’re going on a journey to explore the estimated Pirs Stock Forecast for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Pirs Stock Forecast.
Pieris Pharmaceuticals is a biotechnology company that specializes in the discovery and development of novel biotherapeutics for the treatment of cancer, respiratory, and other diseases.
The company was founded in 2001 and is headquartered in Boston, Massachusetts, USA, with an additional location in Hallbergmoos, Germany. The company’s pipeline includes several programs in clinical and preclinical development for the treatment of various cancers and respiratory diseases.
Pieris Pharmaceuticals is committed to developing superior medicines through efficient biology. The company’s Anticalin platform is designed to address the limitations of traditional protein therapeutics, such as antibodies, by offering a smaller size, greater stability, and improved tissue penetration.
Overview of Pirs
| Name | Pieris Pharmaceuticals, Inc. |
|---|---|
| Symbol | PIRS |
| Industry | Biotechnology |
| Type | Public |
| Founded | 2001 |
| CEO | Stephen S. Yoder |
| Headquarters | Boston, Massachusetts, USA |
| Country | United States |
| Locations | Boston, Massachusetts, USA; Hallbergmoos, Germany |
| Website | pieris.com |
| Profile | Pieris_Pharmaceuticals |
We will analyze the performance of the company’s stocks in recent times and provide you with a well-researched Pirs Stock Forecast for 2023, 2025, 2030 to 2050. Additionally, we will also take into analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation.
Keep an eye on Pirs’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Pirs’s share price.
Pirs Stock Price Live
Fundamentals of Pirs
The fundamental analysis of Pirs Limited focuses on key factors to better understand the company’s valuation.
Pirs Stock Price History
Analyst Recommendations
Daily Low / High
| Telegram Channel | 👉 Click Here 🎯 |
| Facebook Page | 👉 Click Here 🎯 |
Pirs Stock Forecast 2023 to 2050
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Pirs Stock Forecast for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
Pirs Stock Forecast 2023
Based on the company’s financial results and pipeline progress, I predict that the Pirs stock price will range between $0.60 USD and $0.70 USD by the end of 2023. This is due to the expected completion of the Phase 1 study of PRS-220, which is ongoing and expected to generate positive data in the second half of 2023. Additionally, the company’s co-development options for Elarekibep are expected to increase economic benefits to Pieris, which could positively impact the stock price.
Pirs Stock Forecast 2024
In 2024, I predict that the Pirs stock price will range between $1.00 USD and $1.20 USD. This is due to the expected initiation of Phase 2 studies for PRS-220 and Elarekibep, which could generate positive clinical data and increase investor confidence in the company’s pipeline. Additionally, the company’s partnerships with AstraZeneca and Servier could lead to potential milestone payments and royalties, which could positively impact the stock price.
Pirs Stock Forecast 2025
By 2025, I predict that the Pirs stock price will range between $2.00 USD and $2.50 USD. This is due to the expected completion of Phase 2 studies for PRS-220 and Elarekibep, which could generate positive clinical data and lead to regulatory filings. Additionally, the company’s partnerships and collaborations could lead to potential licensing agreements and commercialization deals, which could positively impact the stock price.
Pirs Stock Forecast 2027
In 2027, I predict that the Pirs stock price will range between $6.00 USD and $7.00 USD. This is due to the potential approval and commercialization of PRS-220 and Elarekibep, which could generate significant revenue for the company. Additionally, the company’s partnerships and collaborations could lead to potential licensing agreements and commercialization deals, which could positively impact the stock price.
Pirs Stock Forecast 2030
By 2030, I predict that the Pirs stock price will range between $10.00 USD and $12.00 USD. This is due to the potential approval and commercialization of PRS-220 and Elarekibep, as well as the company’s other pipeline candidates. Additionally, the company’s partnerships and collaborations could lead to potential licensing agreements and commercialization deals, which could positively impact the stock price.
Pirs Stock Forecast 2023 to 2050
| Year | Minimum Target | Maximum Target |
|---|---|---|
| 2023 | $0.60 USD | $0.70 USD |
| 2024 | $1.00 USD | $1.20 USD |
| 2025 | $2.00 USD | $2.50 USD |
| 2026 | $4.00 USD | $5.00 USD |
| 2027 | $6.00 USD | $7.00 USD |
| 2030 | $10.00 USD | $12.00 USD |
Pirs Stock Price in 2015?
– According to Google historical data, the price of Pirs on 2 Jan 2015 was $2.75 USD.
What is the Current Pirs Stock Price?
– As of 24 August 2023, the current stock price of Pirs is $0.44 USD Check out today’s current stock price.
Pirs Stock Forecast 2023?
– Based on our analysis, the maximum Pirs Stock Forecast in 2023 could be $0.70 USD.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Stockdhan and stay connected with us.
I would like to remind you that I am not authorized by the SEC to provide any financial advice or recommendations. As you know, Stock price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– These Stock Price Targets for “Pirs Stock Forecast” are only provided for informational purposes only. It does not constitute a recommendation to buy, sell, or hold Pirs stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
